<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>L. Paracchini | Romualdi Lab</title>
    <link>/author/l.-paracchini/</link>
      <atom:link href="/author/l.-paracchini/index.xml" rel="self" type="application/rss+xml" />
    <description>L. Paracchini</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© Research Group</copyright><lastBuildDate>Fri, 01 Jan 2021 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hud8b169d6400d4e9e77db720aa3284c6d_12325_512x512_fill_lanczos_center_2.png</url>
      <title>L. Paracchini</title>
      <link>/author/l.-paracchini/</link>
    </image>
    
    <item>
      <title>Genome-wide copy-number alterations in circulating tumor DNA as a novel biomarker for patients with high-grade serous ovarian cancer</title>
      <link>/publication/2021-01-01_genome-wide_copy-num/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>/publication/2021-01-01_genome-wide_copy-num/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies</title>
      <link>/publication/2021-01-01_regional_and_tempora/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>/publication/2021-01-01_regional_and_tempora/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer</title>
      <link>/publication/2020-01-01_expression_profiles_/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>/publication/2020-01-01_expression_profiles_/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3</title>
      <link>/publication/2019-01-01_multisite_analysis_o/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/2019-01-01_multisite_analysis_o/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Transcriptional characterization of stage i epithelial ovarian cancer: A multicentric study</title>
      <link>/publication/2019-01-01_transcriptional_char/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/2019-01-01_transcriptional_char/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia</title>
      <link>/publication/2018-01-01_a_systems_biology_ap/</link>
      <pubDate>Mon, 01 Jan 2018 00:00:00 +0000</pubDate>
      <guid>/publication/2018-01-01_a_systems_biology_ap/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts</title>
      <link>/publication/2017-01-01_circulating_mirna_la/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      <guid>/publication/2017-01-01_circulating_mirna_la/</guid>
      <description></description>
    </item>
    
    <item>
      <title>LncRNAs as novel indicators of patients&#39; prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study</title>
      <link>/publication/2017-01-01_lncrnas_as_novel_ind/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      <guid>/publication/2017-01-01_lncrnas_as_novel_ind/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment</title>
      <link>/publication/2016-01-01_a_prognostic_regulat/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      <guid>/publication/2016-01-01_a_prognostic_regulat/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: A retrospective longitudinal analysis using matched tumor biopsies</title>
      <link>/publication/2016-01-01_identification_of_hi/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      <guid>/publication/2016-01-01_identification_of_hi/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study</title>
      <link>/publication/2015-01-01_profiling_cancer_gen/</link>
      <pubDate>Thu, 01 Jan 2015 00:00:00 +0000</pubDate>
      <guid>/publication/2015-01-01_profiling_cancer_gen/</guid>
      <description></description>
    </item>
    
    <item>
      <title>MiRNA landscape in stage i epithelial ovarian cancer defines the histotype specificities</title>
      <link>/publication/2013-01-01_mirna_landscape_in_s/</link>
      <pubDate>Tue, 01 Jan 2013 00:00:00 +0000</pubDate>
      <guid>/publication/2013-01-01_mirna_landscape_in_s/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
